The Kroger Co.
KR
Chevron
CVX
The Kraft Heinz
KHC
Coca-Cola
KO
Occidental Petroleum
OXY
US Stock MarketDetailed Quotes
LGND Ligand Pharmaceuticals
- 116.000
- +0.590+0.51%
Close Mar 6 16:00 ET
- 116.000
- 0.0000.00%
Post 16:04 ET
2.23BMarket Cap-527.27P/E (TTM)
116.650High113.140Low87.40KVolume113.140Open115.410Pre Close10.08MTurnover0.46%Turnover RatioLossP/E (Static)19.26MShares129.90052wk High2.69P/B2.19BFloat Cap67.72052wk Low--Dividend TTM18.85MShs Float173.736Historical High--Div YieldTTM3.04%Amplitude4.115Historical Low115.338Avg Price1Lot Size
About Ligand Pharmaceuticals Company
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Company Profile
SymbolLGND
Company NameLigand Pharmaceuticals
Listing DateNov 17, 1992
Issue Price11.00
Founded1987
CEOMr. Todd C. Davis
MarketNASDAQ
Employees68
Fiscal Year Ends12-31
Address555 Heritage Drive,Suite 200
CityJupiter
ProvinceFlorida
CountryUnited States of America
Zip Code33458
Phone1-858-550-7500
Websitehttp://www.ligand.com
Company Executives
- Name
- Position
- Salary
- Todd C. Davis
- Chief Executive Officer and Director
- 6.22M
- Andrew Reardon
- Chief Legal Officer and Secretary
- 2.34M
- Octavio Espinoza
- Chief Financial Officer and Principal Accounting Officer
- 2.45M
- Dr. John W. Kozarich,PhD
- Chairman of the Board
- 361.70K
- Dr. Nancy Ryan Gray, PhD
- Independent Director
- 339.20K
- Martine Zimmermann, Pharm.D.
- Independent Director
- 467.87K
- Jason M. Aryeh
- Independent Director
- 339.20K
- Jason Haas
- Independent Director
- 346.70K
- Dr. Stephen L. Sabba,M.D.
- Independent Director
- 341.70K
- Dr. John L. LaMattina, PhD
- Independent Director
- 329.20K
Trending Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.